Popular Keywords

Acute Heart Failure

Chronic Heart Failure

Congestive Heart Failure

Coronary Heart Disease

Heart Attack

Heart Defects

Journal of Cardiovascular Diseases, 2025, Volume 12, Issue 1, Pages: 1-16

A Review of Major Skin Cancers: Physiology, Diseases, Market Analysis, and Treatments.

Correspondence to Author: Sophia Welsh, Tawil Bill. 

Department of Bioengineering, University of California, Los Angeles (UCLA), USA

DOI: 10.52338/jocd.2025.4959

Abstract:

Skin cancer is one of the most common cancer types, affecting approximately 20 percent of Americans throughout their lifetime. There are a multitude of types but the majority of skin cancer cases are one of three types: Melanoma, Basal cell carcinoma, and Squamous cell carcinoma. Like most cancers, early detection for skin cancer and access to proper treatments are keys to increasing survival rates. Constant interest in increasing survival rates have led to the combined skin cancer diagnostics and treatment market to have grown to 19.83 billion USD market size as of 2023. The diagnostics are visually based and encompass both a doctor assessment and an additional biopsy for closer identification. The variety of treatments are more extensive than the common diagnostic techniques and include drugs, radiation, and surgery. This review aims to increase understanding of the three major skin cancer types better, including the physiology of the healthy skin, the causes, risks, and detection of skin cancer, the physiology of each different cancer type, the market size, segments, and trends of skin cancer, the current available treatments - both commonplace and tissue engineered, the possible treatment options in clinical trials and being researched.

Keywords: Skin cancer, melanoma, Squamous Cell Carcinoma, Basal Cell Carcinoma, Tissue Engineering

Citation:

Dr. Tawil Bill, A Review of Major Skin Cancers: Physiology, Diseases, Market Analysis, and Treatments. Journal of Cardiovascular Diseases 2025.

Journal Info

  • Journal Name: Journal of Cardiovascular Diseases
  • Impact Factor: 2.08*
  • ISSN: 2831-3437
  • DOI: 10.52338/Jocd
  • Short Name: Jocd
  • Acceptance rate: 55%
  • Volume: 6 (2025)
  • Submission to acceptance: 25 days
  • Acceptance to publication: 10 days
  • Crossref indexed journal
  • Publons indexed journal
  • Pubmed-indexed journal
  • International Scientific Indexing (ISI)-indexed journal
  • Eurasian Scientific Journal Index (ESJI) index journal
  • Semantic Scholar indexed journal
  • Cosmos indexed journal

OUR PUBLICATION BENEFITS

  • International Reach
  • Peer Review
  • Rapid Publication
  • Open Access
  • High Visibility